Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth

Abstract

Despite internal complexity, tumor growth kinetics follow relatively simple laws that can be expressed as mathematical models. To explore this further, quantitative analysis of the most classical of these were performed. The models were assessed against data from two in vivo experimental systems: an ectopic syngeneic tumor (Lewis lung carcinoma) and an orthotopically xenografted human breast carcinoma. The goals were threefold: 1) to determine a statistical model for description of the measurement error, 2) to establish the descriptive power of each model, using several goodness-of-fit metrics and a study of parametric identifiability, and 3) to assess the models' ability to forecast future tumor growth. The models included in the study comprised the exponential, exponential-linear, power law, Gompertz, logistic, generalized logistic, von Bertalanffy and a model with dynamic carrying capacity. For the breast data, the dynamics were best captured by the Gompertz and exponential-linear models. The latter also exhibited the highest predictive power, with excellent prediction scores (≥80%) extending out as far as 12 days in the future. For the lung data, the Gompertz and power law models provided the most parsimonious and parametrically identifiable description. However, not one of the models was able to achieve a substantial prediction rate (≥70%) beyond the next day data point. In this context, adjunction of a priori information on the parameter distribution led to considerable improvement. For instance, forecast success rates went from 14.9% to 62.7% when using the power law model to predict the full future tumor growth curves, using just three data points. These results not only have important implications for biological theories of tumor growth and the use of mathematical modeling in preclinical anti-cancer drug investigations, but also may assist in defining how mathematical models could serve as potential prognostic tools in the clinic.

Modelling Tumor Growth under Angiogenesis Inhibition with Mixed-Effects Models

“…We will use two popular sigmoid models in the present study, for a review of the alternatives, see [8,9,10].…”

A fractional diffusion equation model for cancer tumor

“…Some of these are based upon statistical models 12 with the help of expectation-maximization algorithm or experimental method. 2 In both of these studies, the tumor growth or decay is studied as a function of time. One of the models discussed by Ref.…”

“…One of the models discussed by Ref. 2 has been based upon one dimensional growth equation for different constant rates of cancer cell proliferation. In, Ref.…”

“…One of their major contributions is that the therapy-dependent killing rate K could be a function of both position and time not necessarily constant or time dependent only. (2) in which the killing rate of the cancer cells is dependent on the concentration of the cells, K(u), in more general settings. The model therefore resulted into nonlinear partial differential equation, so they took into account various cases ranging from the simple model for the radially symmetric to the radially non-symmetric tumor.…”

Bayesian Inference of the Stochastic Gompertz Growth Model for Tumor Growth

“…It has a large explanatory power representing real phenomena because all tumors follow a standard growth pattern of fast growth in the beginning and eventually reach a maximum size. Recently this model has been applied to tumor growth and many good examples of this application are available (Benzekry et al, 2014;Bonate et al, 2013). However, the Gompertz growth model often exhibits discrepancies between clinical data and theoretical predictions due to intense environmental fluctuations and varied diversities of patients.…”